Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial.
Abraham H HulstMaarten J VisscherMarc B GodfriedBram ThielBastiaan M GerritseThierry V ScohyR Arthur BouwmanMark G A WillemsenMarkus W HollmannBenedikt PreckelJ Hans DeVriesJeroen Hermanidesnull nullPublished in: Diabetes, obesity & metabolism (2019)
Preoperative liraglutide, compared with placebo, reduces insulin requirements while improving perioperative glycaemic control during cardiac surgery.
Keyphrases
- cardiac surgery
- acute kidney injury
- phase iii
- double blind
- type diabetes
- patients undergoing
- clinical trial
- end stage renal disease
- study protocol
- open label
- phase ii
- placebo controlled
- ejection fraction
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- cross sectional
- patient reported outcomes
- skeletal muscle